Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epilepsy, Focal Seizures, Partial Seizures”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00210522
What this trial is testing

An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy

Who this might be right for
EpilepsyEpilepsies, Partial
SK Life Science, Inc. 421
Not applicableStudy completedNCT00072813
What this trial is testing

MRI in Autosomal Dominant Partial Epilepsy With Auditory Features

Who this might be right for
Epilepsies, Partial
National Institute of Neurological Disorders and Stroke (NINDS) 72
Testing effectiveness (Phase 2)Study completedNCT00465517
What this trial is testing

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

Who this might be right for
Partial EpilepsyCatamenial Epilepsy
Marinus Pharmaceuticals 147
Large-scale testing (Phase 3)Study completedNCT01091662
What this trial is testing

Safety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current Antiepileptic

Who this might be right for
Epilepsy
Sumitomo Pharma America, Inc. 172
Large-scale testing (Phase 3)Study completedNCT00991757
What this trial is testing

An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.

Who this might be right for
EpilepsyComplex Partial SeizuresEpilepsy, Complex Partial+1 more
SK Life Science, Inc. 991
Post-approval studies (Phase 4)Not Yet RecruitingNCT06534502
What this trial is testing

Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures

Who this might be right for
SeizuresSeizures, FocalSeizure, Partial Onset+4 more
Azurity Pharmaceuticals 40
Not applicableStudy completedNCT04770337
What this trial is testing

Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy

Who this might be right for
Refractory EpilepsyFocal SeizureSeizures, Focal+4 more
Neuroelectrics Corporation 127
Testing effectiveness (Phase 2)Study completedNCT02495844
What this trial is testing

UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy

Who this might be right for
Highly Drug-resistant Focal Epilepsy
UCB Biopharma S.P.R.L. 55
Post-approval studies (Phase 4)Study completedNCT00537940
What this trial is testing

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Who this might be right for
EpilepsyPartial Seizure DisorderEpilepsies, Partial+1 more
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 482
Not applicableUnknownNCT05571371
What this trial is testing

Inflammatory Biomarkers in Psychogenic Non-epileptic Seizure

Who this might be right for
Localization-Related (Focal) (Partial) Idiopathic Epilepsy and Epileptic Syndromes With Seizures of Localized OnsetTRAIL: Tumor Necrosis Factor Related Apoptosis Inducing Ligand MCP-2MCP-2: Monocyte Chemo-attractant Protein-2
Esraa Mostafa Ahmed Abdel Aal 90
Testing effectiveness (Phase 2)Study completedNCT02899611
What this trial is testing

A Dose Ranging Pilot Study for Intracerebroventricular (ICV) Delivery of Valproate in Subjects With Temporal Seizures

Who this might be right for
Epilepsy
Cerebral Therapeutics LLC 6
Large-scale testing (Phase 3)Study completedNCT00236886
What this trial is testing

Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients

Who this might be right for
EpilepsyEpilepsies, PartialEpilepsy, Generalized+1 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 49
Large-scale testing (Phase 3)Study completedNCT00988429
What this trial is testing

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Who this might be right for
Partial Epilepsy
Bial - Portela C S.A. 653
Not applicableStudy completedNCT03531008
What this trial is testing

Human Epilepsy Project 2: Resistant Focal Seizures Study

Who this might be right for
EpilepsyBrain DiseasesCentral Nervous System Diseases+2 more
Epilepsy Foundation of America 157
Large-scale testing (Phase 3)Study completedNCT00230698
What this trial is testing

The Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 451
Large-scale testing (Phase 3)Ended earlyNCT00067431
What this trial is testing

The Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children

Who this might be right for
Partial Seizure Disorder
Abbott 300
Testing effectiveness (Phase 2)Study completedNCT00210652
What this trial is testing

An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

Who this might be right for
EpilepsyEpilepsies, Partial
SK Life Science, Inc. 47
Testing effectiveness (Phase 2)Study completedNCT02365610
What this trial is testing

GWP42006 in People With Focal Seizures - Part B

Who this might be right for
EpilepsyFocal Seizures
Jazz Pharmaceuticals 162
Testing effectiveness (Phase 2)Study completedNCT00236860
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 56
Not applicableStudy completedNCT00001325
What this trial is testing

Metabolic Abnormalities in Children With Epilepsy

Who this might be right for
Generalized EpilepsyInfantile SpasmsMetabolic Disease+2 more
National Institute of Neurological Disorders and Stroke (NINDS) 80
Next Page